Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Thailand Inflation Remains Negative for 10th Straight Month in January
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
India Services Sector Rebounds in January as New Business Gains Momentum: HSBC PMI Shows Growth
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding
Asian Markets Wobble as AI Fears Rattle Stocks, Oil and Gold Rebound
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



